Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| 1 |
UnitedHealth
UNH
|
+$2.13B |
| 2 |
Boeing
BA
|
+$879M |
| 3 |
Netflix
NFLX
|
+$878M |
| 4 |
EOG Resources
EOG
|
+$870M |
| 5 |
Wells Fargo
WFC
|
+$741M |
Top Sells
| 1 |
Fidelity National Information Services
FIS
|
+$1.35B |
| 2 |
Nike
NKE
|
+$1.26B |
| 3 |
AbbVie
ABBV
|
+$1.24B |
| 4 |
McDonald's
MCD
|
+$1.15B |
| 5 |
Texas Instruments
TXN
|
+$1.03B |
Sector Composition
| 1 | Healthcare | 21.27% |
| 2 | Technology | 16.8% |
| 3 | Communication Services | 12.6% |
| 4 | Consumer Discretionary | 11.05% |
| 5 | Financials | 7.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
CONMED
CNMD
$1.64B
| $241M | 0.07% |
2,156,651
-113,511
| -5% | -$12.7M |
|
202
ConocoPhillips
COP
$115B
| $240M | 0.07% |
3,687,817
+3,866
| +0.1% | +$251K |
|
203
Workday
WDAY
$59.6B
| $235M | 0.07% |
1,429,237
-3,329,386
| -70% | -$548M |
|
204
Exelon
EXC
$43.8B
| $224M | 0.07% |
6,877,103
+4,185
| +0.1% | +$136K |
|
205
Electronic Arts
EA
$43.1B
| $222M | 0.07% |
2,062,811
+1,277
| +0.1% | +$137K |
|
|
ACC
206
DELISTED
American Campus Communities, Inc.
ACC
| $218M | 0.07% |
4,637,848
+1,188
| +0% | +$55.9K |
|
207
West Pharmaceutical
WST
$18.2B
| $216M | 0.06% |
1,438,129
+1,216
| +0.1% | +$183K |
|
208
Xcel Energy
XEL
$43.4B
| $214M | 0.06% |
3,371,543
+3,378
| +0.1% | +$214K |
|
209
Wyndham Hotels & Resorts
WH
$6.55B
| $203M | 0.06% |
3,224,500
+85,000
| +3% | +$5.34M |
|
210
Lam Research
LRCX
$148B
| $202M | 0.06% |
6,923,000
-738,860
| -10% | -$21.6M |
|
211
Boston Scientific
BSX
$152B
| $202M | 0.06% |
4,465,937
+7,170
| +0.2% | +$324K |
|
212
XP
XP
$9.94B
| $199M | 0.06% |
+5,164,688
| New | +$199M |
|
213
IBM
IBM
$236B
| $193M | 0.06% |
1,509,938
+1,878
| +0.1% | +$241K |
|
214
Caterpillar
CAT
$202B
| $191M | 0.06% |
1,292,099
+793
| +0.1% | +$117K |
|
215
Estee Lauder
EL
$30.1B
| $190M | 0.06% |
+921,305
| New | +$190M |
|
|
AZUL
216
DELISTED
Azul
AZUL
| $184M | 0.06% |
4,296,315
-2,385,201
| -36% | -$102M |
|
|
IPHI
217
DELISTED
INPHI CORPORATION
IPHI
| $183M | 0.05% |
2,471,873
-84,444
| -3% | -$6.25M |
|
218
Novartis
NVS
$240B
| $181M | 0.05% |
1,912,635
+3,839
| +0.2% | +$364K |
|
219
Ametek
AME
$43.9B
| $180M | 0.05% |
1,802,563
-1,713,657
| -49% | -$171M |
|
220
US Bancorp
USB
$76.5B
| $178M | 0.05% |
3,003,841
+2,054
| +0.1% | +$122K |
|
221
Edison International
EIX
$21.6B
| $173M | 0.05% |
2,292,402
+697,452
| +44% | +$52.6M |
|
222
Dine Brands
DIN
$368M
| $170M | 0.05% |
2,039,724
+240,509
| +13% | +$20.1M |
|
223
Allogene Therapeutics
ALLO
$251M
| $170M | 0.05% |
6,542,678
+1,268,228
| +24% | +$32.9M |
|
224
LivaNova
LIVN
$3.07B
| $166M | 0.05% |
2,205,946
-164,772
| -7% | -$12.4M |
|
225
Petrobras Class A
PBR.A
$75.2B
| $158M | 0.05% |
10,577,961
-4,147,579
| -28% | -$61.9M |
|